Ibufenac-13C6

Ibufenac-13C6 (Dytransin-13C6) is the 13C-labeled Ibufenac. Ibufenac (Dytransin) is an orally active nonsteroidal anti-inflammatory agent. Ibufenac exerts anti-inflammatory, analgesic and antipyretic effects. Ibufenac is being studied for the treatment of rheumatic diseases such as rheumatoid arthritis[1][2].

Dytransin-13C6

12352005

COX; Isotope-Labeled Compounds

Immunology/Inflammation; Others

COVID-19-immunoregulation

Inflammation/Immunology

CC(C)C[13C]1=[13C]([H])[13C]([H])=[13C](CC(O)=O)[13C]([H])=[13C]1[H]

C6 13C6H16O2

198.21

[1]Rao CS, et al. Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye. J Pharmacokinet Biopharm. 1992 Aug;20 (4) :357-88.|[2]Rao CS, et al. Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye. J Pharmacokinet Biopharm. 1992 Aug;20 (4) :357-88.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-W756637/

Isotope-Labeled Compounds

No Development Reported